Cancer Immunotherapy, Part 3: Challenges and Future Trends.

about

Survivin-Based Treatment Strategies for Squamous Cell Carcinoma.An Update on Predictive Biomarkers for Treatment Selection in Non-Small Cell Lung Cancer.

P2860

Q51758973-FCFD51CD-E419-44A5-9C97-CA7EA4461A6C Q55515425-F389FB68-6ACA-49E2-97A5-329E43AD972B

P2860

Cancer Immunotherapy, Part 3: Challenges and Future Trends.

Item

http://www.wikidata.org/entity/Q38646290

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Cancer Immunotherapy, Part 3: Challenges and Future Trends.

@en

type

Item

label

Cancer Immunotherapy, Part 3: Challenges and Future Trends.

@en

prefLabel

Cancer Immunotherapy, Part 3: Challenges and Future Trends.

@en

P1476

Cancer Immunotherapy, Part 3: Challenges and Future Trends.

@en

P2093

C Lee Ventola

http://www.w3.org/2001/XMLSchema#string

P2860

Improved endpoints for cancer immunotherapy trials

Clinical trial results of the HER-2/neu (E75) vaccine to prevent breast cancer recurrence in high-risk patients: from US Military Cancer Institute Clinical Trials Group Study I-01 and I-02

Novel technologies and emerging biomarkers for personalized cancer immunotherapy

Next-generation sequencing to guide cancer therapy

Mechanisms of acquired crizotinib resistance in ALK-rearranged lung Cancers.

Non-genomic and Immune Evolution of Melanoma Acquiring MAPKi Resistance

Nivolumab in previously untreated melanoma without BRAF mutation

Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial.

The immuno-oncology framework: Enabling a new era of cancer therapy.

Neoantigens in cancer immunotherapy.

P304

514-521

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28781505

http://www.w3.org/2001/XMLSchema#string

P932

5521300

http://www.w3.org/2001/XMLSchema#string

Cancer Immunotherapy, Part 3: Challenges and Future Trends.

about

P2860

P2860

Cancer Immunotherapy, Part 3: Challenges and Future Trends.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P577

P698

P932

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P577

P698

P932